The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2015
Filed:
Apr. 25, 2013
Applicants:
MD Bioalpha Co., Ltd., Daejeon, KR;
Kt & G Co., Ltd., Daejeon, KR;
Inventors:
Sang-Ku Yoo, Gwacheon-si, KR;
Myunggyu Park, Yongin-si, KR;
In Geun Jo, Cheonan-si, KR;
Taehwan Kwak, Yongin-si, KR;
Assignees:
MD BIOALPHA CO., LTD., Daejeon, KR;
KT & G CO., LTD., Daejeon, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/00 (2006.01); A61K 31/33 (2006.01); A01N 43/16 (2006.01); A61K 31/35 (2006.01); A61K 31/352 (2006.01); A61K 31/343 (2006.01); A61K 31/353 (2006.01); A61K 31/453 (2006.01);
U.S. Cl.
CPC ...
A61K 31/352 (2013.01); A61K 31/343 (2013.01); A61K 31/353 (2013.01); A61K 31/453 (2013.01);
Abstract
Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.